{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/novo-nordisk-class-b/","json":"https://alysly.com/json/markets/stocks/novo-nordisk-class-b/index.json","lang":"en-US","title":"Novo Nordisk Class B (NOVO B) Stock Price | News","description":"Novo Nordisk Class B (NOVO B). Health Care stock, Denmark. Held in 4 ETFs (top 0.93% in IMEA). Chart, performance and cross-asset correlations.","modified":"2026-11-02T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/novo-nordisk-class-b/","json":"https://alysly.com/json/de/maerkte/aktien/novo-nordisk-class-b/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Novo Nordisk Class B","url":"https://alysly.com/markets/stocks/novo-nordisk-class-b/"}],"content":[{"type":"heading","level":1,"text":"Novo Nordisk Class B (NOVO B)"},{"type":"paragraph","text":"NOVO B · Health Care · Denmark","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"Denmark","href":"https://alysly.com/markets/stocks/browse/?country=Denmark"}]},{"type":"paragraph","text":"Novo Nordisk Class B (NOVO B) is a Danish company in the Health Care sector. The stock has its largest weight in IMEA (MSCI Europe), at 0.93%. Anyone who holds an ETF containing Novo Nordisk also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Novo Nordisk"},{"type":"heading","level":3,"text":"Key Data for Novo Nordisk"},{"type":"facts","items":[{"label":"Held in","value":"4 ETFs"},{"label":"Highest weight","value":"0.93%"},{"label":"Indices","value":"4"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"Denmark"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Novo Nordisk"},{"type":"heading","level":3,"text":"What ETF Is Novo Nordisk In?"},{"type":"paragraph","text":"Novo Nordisk has average ETF coverage and is held by 4 of the 104 ETFs we track, which together follow 4 indices. That puts the stock in more ETFs than 41.1% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"table","caption":"What ETF is Novo Nordisk in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"IMEA","href":"https://alysly.com/markets/etfs/ishares-core-msci-europe-ucits-etf-eur-acc/"},{"text":"MSCI Europe","href":"https://alysly.com/markets/indices/msci-europe/"},"0.93%","€9.30"],[{"text":"EXSA","href":"https://alysly.com/markets/etfs/ishares-stoxx-europe-600-ucits-etf-de/"},{"text":"STOXX Europe 600","href":"https://alysly.com/markets/indices/stoxx-600/"},"0.85%","€8.50"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.14%","€1.40"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.12%","€1.20"]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Novo Nordisk, based on each fund's latest holdings list."},{"type":"list","ordered":false,"items":[{"text":"Novo Nordisk among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 4 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"Novo Nordisk Weight in iShares Core MSCI World (EUNL) Since 2019"},{"type":"image","alt":"Novo Nordisk: weight in EUNL 0.23% → 0.14%"},{"type":"paragraph","text":"Sep 30, 2019 Oct 30, 2026"},{"type":"paragraph","text":"In iShares Core MSCI World (EUNL), Novo Nordisk had a weight of 0.23% on Sep 30, 2019 and 0.14% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.71% on Jun 28, 2024. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares Core MSCI World (EUNL)","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"}]},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Novo Nordisk overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Novo Nordisk"},{"type":"table","caption":"Stocks with ETF exposure similar to Novo Nordisk","columns":["Stock","Shared ETFs","r"],"rows":[["Novo Nordisk","–","–"],[{"text":"Danske Bank","href":"https://alysly.com/markets/stocks/danske-bank/"},"4","–"],[{"text":"Compass Group","href":"https://alysly.com/markets/stocks/compass-group-plc/"},"4","–"],[{"text":"Dieteren (D)","href":"https://alysly.com/markets/stocks/dieteren-d-sa/"},"4","–"],[{"text":"GALP Energia SGPS","href":"https://alysly.com/markets/stocks/galp-energia-sgps-sa-class-b/"},"4","–"],[{"text":"Heineken","href":"https://alysly.com/markets/stocks/heineken-nv/"},"4","–"],[{"text":"Heineken Holding","href":"https://alysly.com/markets/stocks/heineken-holding-nv/"},"4","–"],[{"text":"Hennes & Mauritz","href":"https://alysly.com/markets/stocks/hennes-mauritz/"},"4","–"],[{"text":"Industrivarden","href":"https://alysly.com/markets/stocks/industrivarden-series/"},"4","–"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Novo Nordisk. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Novo Nordisk"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 2, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-3","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-4","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-5","text":"Selected by how many of the funds we track hold both names, not by business model."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/novo-nordisk-class-b/#webpage","url":"https://alysly.com/markets/stocks/novo-nordisk-class-b/","name":"Novo Nordisk Class B – Alysly","description":"Novo Nordisk Class B (NOVO B). Health Care stock, Denmark. Held in 4 ETFs (top 0.93% in IMEA). Chart, performance and cross-asset correlations.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-02T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/novo-nordisk-class-b/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Novo Nordisk Class B"}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/novo-nordisk-class-b/#entity","name":"Novo Nordisk Class B","tickerSymbol":"NOVO B","url":"https://alysly.com/markets/stocks/novo-nordisk-class-b/","mainEntityOfPage":"https://alysly.com/markets/stocks/novo-nordisk-class-b/","description":"Novo Nordisk Class B (NOVO B). Health Care stock, Denmark. Held in 4 ETFs (top 0.93% in IMEA). Chart, performance and cross-asset correlations.","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"NOVO B"}],"address":{"@type":"PostalAddress","addressCountry":"DK"},"subjectOf":{"@type":"Dataset","name":"Novo Nordisk Class B — key figures","url":"https://alysly.com/markets/stocks/novo-nordisk-class-b/","description":"Novo Nordisk Class B (NOVO B). Health Care stock, Denmark. Held in 4 ETFs (top 0.93% in IMEA). Chart, performance and cross-asset correlations.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":4},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":0.93},{"@type":"PropertyValue","name":"Sector","value":"Health Care"}]}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}